Mechanisms of the depot specificity of peroxisome proliferator-activated receptor γ action on adipose tissue metabolism

Diabetes

Volumn 55, Issue 10, 2006, Pages 2771-2778

  Laplante, Mathieu ^a   Festuccia, William T ^a   Soucy, Geneviève ^a   Gélinas, Yves ^a   Lalonde, Josée ^a   Berger, Joel P ^b   Deshaies, Yves ^a  

^a LAVAL UNIVERSITY   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 (4 PHENOXY 2 PROPYLPHENOXY)ETHYL]INDOLE 5 ACETIC ACID; DIACYLGLYCEROL ACYLTRANSFERASE; FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; TRIACYLGLYCEROL; (PYRUVATE DEHYDROGENASE (LIPOAMIDE))KINASE; 2 (2 (4 PHENOXY 2 PROPYLPHENOXY)ETHYL)INDOLE 5 ACETIC ACID; 2-(2-(4-PHENOXY-2-PROPYLPHENOXY)ETHYL)INDOLE-5-ACETIC ACID; ACETIC ACID DERIVATIVE; CARNITINE PALMITOYLTRANSFERASE; INDOLE DERIVATIVE; ION CHANNEL; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; PGC 1ALPHA PROTEIN, RAT; PGC-1ALPHA PROTEIN, RAT; PROTEIN KINASE; PYRUVATE DEHYDROGENASE KINASE 4; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CONTROLLED STUDY; ENERGY EXPENDITURE; ESTERIFICATION; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE BLOOD LEVEL; GLYCEROL BLOOD LEVEL; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPID TRANSPORT; LIPOLYSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS FAT; THERMOGENESIS; TISSUE METABOLISM; TISSUE SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; ADIPOCYTE; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; ENERGY METABOLISM; HISTOLOGY; METABOLISM; MITOCHONDRION; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ACETIC ACIDS; ACYL-COA DEHYDROGENASE, LONG-CHAIN; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; ENERGY METABOLISM; FATTY ACIDS; GLYCEROL; INDOLES; INTRA-ABDOMINAL FAT; ION CHANNELS; LIPOLYSIS; MALE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PPAR GAMMA; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA-BINDING PROTEINS; SUBCUTANEOUS FAT; TRANSCRIPTION FACTORS;

EID: 33750846938     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0551     Document Type: Article

References (48)

1. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260, 1982
2. Kannel WB, Cupples LA, Ramaswami R, Stokes J 3rd, Kreger BE, Higgins M: Regional obesity and risk of cardiovascular disease: the Framingham Study. J Clin Epidemiol 44:183-190, 1991
3. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U: Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 72:1150-1162, 1983
4. Wajchenberg BL: Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738, 2000
5. Jensen MD: Lipolysis: contribution from regional fat. Annu Rev Nutr 17:127-139, 1997
6. Lam TK, Carpentier A, Lewis GF, van de Werve G, Fantus IG, Giacca A: Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol 284:E863-E873, 2003
7. Lewis GF: Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 8:146-153, 1997
8. Kanety H, Hemi R, Papa MZ, Karasik A: Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 271:9895-9897, 1996
9. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236, 2002
10. Lyon CJ, Law RE, Hsueh WA: Minireview: Adiposity, inflammation, and atherogenesis. Endocrinology 144:2195-2200, 2003
11. Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, Straubhaar J, Czech MP, Corvera S: Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 114:1281-1289, 2004
12. Boden G, Homko C, Mozzoli M, Showe LC, Nichols C, Cheung P: Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients. Diabetes 54:880-885, 2005
13. de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF: Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 50:1863-1871, 2001
14. Mori Y, Murakawa Y, Okada K, Horikoshi H, Yokoyama J, Tajima N, Ikeda Y: Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care 22:908-912, 1999
15. Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA: Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87:2784-2791, 2002
16. Smith SR, De Jonge L, Volaufova J, Li Y, Xie H, Bray GA: Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial. Metabolism 54:24-32, 2005
17. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, O'Rahilly S: Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100:3149-3153, 1997
18. Sewter CP, Blows F, Vidal-Puig A, O'Rahilly S: Regional differences in the response of human pre-adipocytes to PPARγ and RXRα agonists. Diabetes 51:718-723, 2002
19. Laplante M, Sell H, MacNaul KL, Richard D, Berger JP, Deshaies Y: PPAR-γ activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes 52:291-299, 2003
20. Picard F, Boivin A, Lalonde J, Deshaies Y: Resistance of adipose tissue lipoprotein lipase to insulin action in rats fed an obesity-promoting diet. Am J Physiol 282:E412-E418, 2002
21. Picard F, Naimi N, Richard D, Deshaies Y: Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. Diabetes 48:452-459, 1999
22. Brito MN, Brito NA, Brito SR, Moura MA, Kawashita NH, Kettelhut IC, Migliorini RH: Brown adipose tissue triacylglycerol synthesis in rats adapted to a high-protein, carbohydrate-free diet. Am J Physiol 276:R1003-R1009, 1999
23. Rodbell M: Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380, 1964
24. Hultin M, Carneheim C, Rosenqvist K, Olivecrona T: Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons. J Lipid Res 36:2174-2184, 1995
25. Festuccia WT, Kawashita NH, Garofalo MA, Moura MA, Brito SR, Kettelhut IC, Migliorini RH: Control of glyceroneogenic activity in rat brown adipose tissue. Am J Physiol 285:R177-R182, 2003
26. Tordjman J, Chauvet G, Quette J, Beale EG, Forest C, Antoine B: Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem 278:18785-18790, 2003
27. MacDonald MJ, Grewe BK: Inhibition of phosphoenolpyruvate carboxykinase, glyceroneogenesis and fatty acid synthesis in rat adipose tissue by quinolinate and 3-mercaptopicolinate. Biochim Biophys Acta 663:302-313, 1981
28. Berger J, Moller DE: The mechanisms of action of PPARs. Annu Rev Med 53:409-435, 2002
29. Spiegelman BM: PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514, 1998
30. Chen HC, Stone SJ, Zhou P, Buhman KK, Farese RV Jr: Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme A: diacylglycerol acyltransferase 1 in white adipose tissue. Diabetes 51:3189-3195, 2002
31. Oakes ND, Thalen PG, Jacinto SM, Ljung B: Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes 50:1158-1165, 2001
32. Kalderon B, Mayorek N, Ben-Yaacov L, Bar-Tana J: Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo. Am J Physiol 284:E795-E803, 2003
33. Festuccia WT, Laplante M, Berthiaume M, Gélinas Y, Deshaies Y: PPARγ agonism increases rat adipose tissue lipolysis, expression of acylglycerol lipases, and the response of lipolysis to hormonal control. Diabetologia. In press
34. Ye JM, Dzamko N, Cleasby ME, Hegarty BD, Furler SM, Cooney GJ, Kraegen EW: Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin. Diabetologia 47:1306-1313, 2004
35. Coort SL, Coumans WA, Bonen A, van der Vusse GJ, Glatz JF, Luiken JJ: Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats. J Lipid Res 46:1295-1302, 2005
36. Faraj M, Sniderman AD, Cianflone K: ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J Lipid Res 45:657-666, 2004
37. Toseland CD, Campbell S, Francis I, Bugelski PJ, Mehdi N: Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat. Diabetes Obes Metab 3:163-170, 2001
38. Bogacka I, Xie H, Bray GA, Smith SR: Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54:1392-1399, 2005
39. Holness MJ, Sugden MC: Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem Soc Trans 31:1143-1151, 2003
40. Way JM, Harrington WW, Brown KK, Gottschalk WK, Sundseth SS, Mansfield TA, Ramachandran RK, Willson TM, Kliewer SA: Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor γ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Endocrinology 142:1269-1277, 2001
41. Lin J, Handschin C, Spiegelman BM: Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361-370, 2005
42. Tiraby C, Tavernier G, Lefort C, Larrouy D, Bouillaud F, Ricquier D, Langin D: Acquirement of brown fat cell features by human white adipocytes. J Biol Chem 278:33370-33376, 2003
43. Yanase T, Yashiro T, Takitani K, Kato S, Taniguchi S, Takayanagi R, Nawata H: Differential expression of PPAR γ1 and γ2 isoforms in human adipose tissue. Biochem Biophys Res Commun 233:320-324, 1997
44. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, Vidal H: Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47:98-103, 1998
45. Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, Byrne CD, O'Rahilly S: Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47:1384-1391, 1998
46. Rodriguez E, Ribot J, Rodriguez AM, Palou A: PPAR-γ2 expression in response to cafeteria diet: gender- and depot-specific effects. Obes Res 12:1455-1463, 2004
47. Picard F, Gehin M, Annicotte J, Rocchi S, Champy MF, O'Malley BW, Chambon P, Auwerx J: SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111:931-941, 2002
48. Leonardsson G, Steel JH, Christian M, Pocock V, Milligan S, Bell J, So PW, Medina-Gomez G, Vidal-Puig A, White R, Parker MG: Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci U S A 101:8437-8442, 2004